Rockefeller Capital Management’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23
Closed -$104 4730
2025
Q4
$104 Sell
23
-138
-86% -$707 ﹤0.01% 4624
2025
Q3
$868 Buy
+161
New +$871 ﹤0.01% 4207

Rockefeller Capital Management's CVAC Position: Q1 2026 in Review

Rockefeller Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 23 shares — an estimated $104 sold.

Rockefeller Capital Management first reported a position in CVAC in Q3 2025 and held it in 2 quarters. The position peaked at $868 in Q3 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Rockefeller Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 23 CureVac shares in Q1 2026, an estimated $104.
  • Rockefeller Capital Management first reported a position in CureVac in Q3 2025 and held it in 2 quarters.
  • Rockefeller Capital Management's CureVac position peaked at $868 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.